The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child
Open accessAbstract
BACKGROUND: There is evidence that certain antiepileptic drugs (AEDs) are teratogenic and are associated with an increased risk of congenital malformation. The majority of women with epilepsy continue taking AEDs throughout pregnancy; therefore it is important that comprehensive information on the potential risks associated with AED treatment is available. OBJECTIVES: To assess the effects of prenatal exposure to AEDs on the prevalence of congenital malformations in the child. SEARCH METHODS: We searched the Cochrane Epilepsy Group Specialized Register (September 2015), Cochrane Central Register of Controlled Trials (CENTRAL) (2015, Issue 11), MEDLINE (via Ovid) (1946 to September 2015), EMBASE (1974 to September 2015), Pharmline (1978 to September 2015), Reprotox (1983 to September 2015) and conference abstracts (2010-2015) without language restriction. SELECTION CRITERIA: We included prospective cohort controlled studies, cohort studies set within pregnancy registries and randomised controlled trials. Participants were women with epilepsy taking AEDs; the two control groups were women without epilepsy and women with epilepsy who were not taking AEDs during pregnancy. DATA COLLECTION AND ANALYSIS: Three authors independently selected studies for inclusion. Five authors completed data extraction and risk of bias assessments. The primary outcome was the presence of a major congenital malformation. Secondary outcomes included specific types of major congenital malformations. Where meta-analysis was not possible, we reviewed included studies narratively. MAIN RESULTS: We included 50 studies, with 31 contributing to meta-analysis. Study quality varied, and given the observational design, all were at high risk of certain biases. However, biases were balanced across the AEDs investigated and we believe that the results are not explained by these biases.Children exposed to carbamazepine (CBZ) were at a higher risk of malformation than children born to women without epilepsy (N = 1367 vs 2146, risk ratio (RR) 2.01, 95% confidence interval (CI) 1.20 to 3.36) and women with untreated epilepsy (N = 3058 vs 1287, RR 1.50, 95% CI 1.03 to 2.19). Children exposed to phenobarbital (PB) were at a higher risk of malformation than children born to women without epilepsy (N = 345 vs 1591, RR 2.84, 95% CI 1.57 to 5.13). Children exposed to phenytoin (PHT) were at an increased risk of malformation compared with children born to women without epilepsy (N = 477 vs 987, RR 2.38, 95% CI 1.12 to 5.03) and to women with untreated epilepsy (N = 640 vs 1256, RR 2.40, 95% CI 1.42 to 4.08). Children exposed to topiramate (TPM) were at an increased risk of malformation compared with children born to women without epilepsy (N = 359 vs 442, RR 3.69, 95% CI 1.36 to 10.07). The children exposed to valproate (VPA) were at a higher risk of malformation compared with children born to women without epilepsy (N = 467 vs 1936, RR 5.69, 95% CI 3.33 to 9.73) and to women with untreated epilepsy (N = 1923 vs 1259, RR 3.13, 95% CI 2.16 to 4.54). There was no increased risk for major malformation for lamotrigine (LTG). Gabapentin (GBP), levetiracetam (LEV), oxcarbazepine (OXC), primidone (PRM) or zonisamide (ZNS) were not associated with an increased risk, however, there were substantially fewer data for these medications.For AED comparisons, children exposed to VPA had the greatest risk of malformation (10.93%, 95% CI 8.91 to 13.13). Children exposed to VPA were at an increased risk of malformation compared with children exposed to CBZ (N = 2529 vs 4549, RR 2.44, 95% CI 2.00 to 2.94), GBP (N = 1814 vs 190, RR 6.21, 95% CI 1.91 to 20.23), LEV (N = 1814 vs 817, RR 5.82, 95% CI 3.13 to 10.81), LTG (N = 2021 vs 4164, RR 3.56, 95% CI 2.77 to 4.58), TPM (N = 1814 vs 473, RR 2.35, 95% CI 1.40 to 3.95), OXC (N = 676 vs 238, RR 3.71, 95% CI 1.65 to 8.33), PB (N = 1137 vs 626, RR 1.59, 95% CI 1.11 to 2.29, PHT (N = 2319 vs 1137, RR 2.00, 95% CI 1.48 to 2.71) or ZNS (N = 323 vs 90, RR 17.13, 95% CI 1.06 to 277.48). Children exposed to CBZ were at a higher risk of malformation than those exposed to LEV (N = 3051 vs 817, RR 1.84, 95% CI 1.03 to 3.29) and children exposed to LTG (N = 3385 vs 4164, RR 1.34, 95% CI 1.01 to 1.76). Children exposed to PB were at a higher risk of malformation compared with children exposed to GBP (N = 204 vs 159, RR 8.33, 95% CI 1.04 to 50.00), LEV (N = 204 vs 513, RR 2.33, 95% CI 1.04 to 5.00) or LTG (N = 282 vs 1959, RR 3.13, 95% CI 1.64 to 5.88). Children exposed to PHT had a higher risk of malformation than children exposed to LTG (N = 624 vs 4082, RR 1.89, 95% CI 1.19 to 2.94) or to LEV (N = 566 vs 817, RR 2.04, 95% CI 1.09 to 3.85); however, the comparison to LEV was not significant in the random-effects model. Children exposed to TPM were at a higher risk of malformation than children exposed to LEV (N = 473 vs 817, RR 2.00, 95% CI 1.03 to 3.85) or LTG (N = 473 vs 3975, RR 1.79, 95% CI 1.06 to 2.94). There were no other significant
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Common antiepileptic drugs in pregnancy in women with epilepsy
Adab, N., Smith, C. T., Vinten, J., Williamson, P. R., & Winterbottom, J. B. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004848 · Cited by 120
Self-citationRetractedGRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Morrow, J. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.074203 · Cited by 880
Tomson, T., Battino, D., Bonizzoni, E., Craig, J., Lindhout, D., Sabers, A., Perucca, E., & Vajda, F. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70107-7 · Cited by 751
Comparative safety of antiepileptic drugs during pregnancy
Hernández-Díaz, S., Smith, C. R., Shen, A., Mittendorf, R., Hauser, W. A., Yerby, M., Holmes, L. B., For the North American AED Pregnancy Registry, North American AED (Antiepileptic Drug) Pregnancy Registry, Cragan, J., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182574f39 · Cited by 620
Valproic Acid Monotherapy in Pregnancy and Major Congenital Malformations
Jentink, J., Loane, M. A., Dolk, H., Barisic, I., Garne, E., Morris, J. K., & de Jong-van den Berg, L. T. W. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907328 · Cited by 587
Epilepsy: Frequency, causes and consequences
Messenheimer, J. A. (1991) · Journal of Epilepsy · doi:10.1016/0896-6974(91)90095-z · Cited by 562
Pattern of Malformations in the Children of Women Treated with Carbamazepine during Pregnancy
Jones, K. L., Lacro, R. V., Johnson, K. A., & Adams, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906223202505 · Cited by 447
Samrén, E. B., van Duijn, C. M., Koch, S., Hiilesmaa, V. K., Klepel, H., Bardy, A. H., Mannagetta, G. B., Deichl, A. W., Gaily, E., Granström, I. L., et al. (1997) · Epilepsia · doi:10.1111/j.1528-1157.1997.tb01480.x · Cited by 406
Meador, K., Reynolds, M. W., Crean, S., Fahrbach, K., & Probst, C. (2008) · Epilepsy Research · doi:10.1016/j.eplepsyres.2008.04.022 · Cited by 400
Increased rate of major malformations in offspring exposed to valproate during pregnancy
Wyszynski, D. F., Nambisan, M., Surve, T., Alsdorf, R. M., Smith, C. R., & Holmes, L. B. (2005) · Neurology · doi:10.1212/01.wnl.0000154516.43630.c5 · Cited by 390
Congenital malformations due to antiepileptic drugs
Kaneko, S., Battino, D., Andermann, E., Wada, K., Kan, R., Takeda, A., Nakane, Y., Ogawa, Y., Avanzini, G., Fumarola, C., et al. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(98)00084-9 · Cited by 374
Seizure control and treatment in pregnancy: Observations from the EURAP Epilepsy Pregnancy Registry
The EURAP Study Group (2006) · Neurology · doi:10.1212/01.wnl.0000195888.51845.80 · Cited by 331
Topiramate in pregnancy: Preliminary experience from the UK Epilepsy and Pregnancy Register
Hunt, S., Russell, A., Smithson, W. H., Parsons, L., Robertson, I., Waddell, R., Irwin, B., Morrison, P. J., Morrow, J., & Craig, J. (2008) · Neurology · doi:10.1212/01.wnl.0000318293.28278.33 · Cited by 312
Antiepileptic drug use of women with epilepsy and congenital malformations in offspring
Artama, M., Auvinen, A., Raudaskoski, T., Isojärvi, I., & Isojärvi, J. (2005) · Neurology · doi:10.1212/01.wnl.0000163771.96962.1f · Cited by 305
Verification of the fetal valproate syndrome phenotype
Ardinger, H. H., Atkin, J. F., Blackston, R. D., Elsas, L. J., Clarren, S. K., Livingstone, S., Flannery, D. B., Pellock, J. M., Harrod, M. J., Lammer, E. J., et al. (1988) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320290123 · Cited by 302
Nakane, Y., Okuma, T., Takahashi, R., Sato, Y., Wada, T., Sato, T., Fukushima, Y., Kumashiro, H., Ono, T., Takahashi, T., et al. (1980) · Epilepsia · doi:10.1111/j.1528-1157.1980.tb04320.x · Cited by 301
Campbell, E., Kennedy, F., Russell, A., Smithson, W. H., Parsons, L., Morrison, P. J., Liggan, B., Irwin, B., Delanty, N., Hunt, S. J., et al. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306318 · Cited by 292
Jäger-Roman, E., Deichl, A., Jakob, S., Hartmann, A.-M., Koch, S., Rating, D., Steldinger, R., Nau, H., & Helge, H. (1986) · The Journal of Pediatrics · doi:10.1016/s0022-3476(86)80949-0 · Cited by 282
Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child
Bromley, R., Weston, J., Adab, N., Greenhalgh, J., Sanniti, A., McKay, A. J., Tudur Smith, C., & Marson, A. G. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010236.pub2 · Cited by 277
Self-citationIn utero antiepileptic drug exposure: Fetal death and malformations
Meador, K. J., Baker, G. A., Finnell, R. H., Kalayjian, L. A., Liporace, J. D., Loring, D. W., Mawer, G., Pennell, P. B., Smith, J. C., & Wolff, M. C. (2006) · Neurology · doi:10.1212/01.wnl.0000227919.81208.b2 · Cited by 277
Wide, K., Winbladh, B., & Källén, B. (2004) · Acta Paediatrica · doi:10.1111/j.1651-2227.2004.tb00701.x · Cited by 264
ANTICONVULSANTS AND PARENTAL EPILEPSY IN THE DEVELOPMENT OF BIRTH DEFECTS
Shapiro, S., Hartz, S., Siskind, V., Mitchell, A., Slone, D., Rosenberg, L., Monson, R., Heinonen, O., Idänpàan-Heikkilä, J., Häró, S., et al. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91403-3 · Cited by 263
The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort.
Omtzigt, J. G. C., Los, F. J., Grobbee, D. E., Pijpers, L., Jahoda, M. G. J., Brandenburg, H., Stewart, P. A., Gaillard, H. L., Sachs, E. S., & Wladimiroff, J. W. (1992) · PubMed · Cited by 252
Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy
Holmes, L. B., Baldwin, E. J., Smith, C. R., Habecker, E., Glassman, L., Wong, S. L., & Wyszynski, D. F. (2008) · Neurology · doi:10.1212/01.wnl.0000304343.45104.d6 · Cited by 249
Newer-Generation Antiepileptic Drugs and the Risk of Major Birth Defects
Mølgaard-Nielsen, D., & Hviid, A. (2011) · JAMA · doi:10.1001/jama.2011.624 · Cited by 248
ANTICONVULSANTS AND PARENTAL EPILEPSY IN THE DEVELOPMENT OF BIRTH DEFECTS
SHAPIRO, S., SLONE, D., HARTZ, S. C., ROSENBERG, L., SISKIND, V., MONSON, R. R., MITCHELL, A. A., & HEINONEN, O. P. (1976) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-197608000-00012 · Cited by 245
Government service and freedom.
MOLONY, J. B. W. D. (1947) · PubMed · Cited by 244
Diphenylhydantoin and Selected Congenital Malformations
Monson, R. R., Rosenberg, L., Hartz, S. C., Shapiro, S., Heinonen, O. P., & Slone, D. (1973) · New England Journal of Medicine · doi:10.1056/nejm197311152892001 · Cited by 240
Jentink, J., Dolk, H., Loane, M. A., Morris, J. K., Wellesley, D., Garne, E., de Jong-van den Berg, L., & for the EUROCAT Antiepileptic Study Working Group (2010) · BMJ · doi:10.1136/bmj.c6581 · Cited by 227
Major malformations in offspring of women with epilepsy
Kaaja, E., Kaaja, R., & Hiilesmaa, V. (2003) · Neurology · doi:10.1212/01.wnl.0000044157.28073.dc · Cited by 218
Epilepsy and Pregnancy: A Study of 153 Pregnancies in 59 Patients
Knight, A. H., & Rhind, E. G. (1975) · Epilepsia · doi:10.1111/j.1528-1157.1975.tb04726.x · Cited by 209
Lindhout, D., Höppener, R. J. E. A., & Meinardi, H. (1984) · Epilepsia · doi:10.1111/j.1528-1157.1984.tb04158.x · Cited by 208
Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy
Veiby, G., Daltveit, A. K., Engelsen, B. A., & Gilhus, N. E. (2014) · Journal of Neurology · doi:10.1007/s00415-013-7239-x · Cited by 196
Malformations in Offspring of Women with Epilepsy: A Prospective Study
Canger, R., Battino, D., Canevini, M. P., Fumarola, C., Guidolin, L., Vignoli, A., Mamoli, D., Palmieri, C., Molteni, F., Granata, T., et al. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00851.x · Cited by 196
Population based, prospective study of the care of women with epilepsy in pregnancy
Fairgrieve, S. D. (2000) · BMJ · doi:10.1136/bmj.321.7262.674 · Cited by 192
Teratogenicity of Antiepileptic Drugs: Analysis of Possible Risk Factors
Kaneko, S., Otani, K., Fukushima, Y., Ogawa, Y., Nomura, Y., Ono, T., Nakane, Y., Teranishi, T., & Goto, M. (1988) · Epilepsia · doi:10.1111/j.1528-1157.1988.tb03746.x · Cited by 182
Fetal Effects of Anticonvulsant Polytherapies: Different Risks From Different Drug Combinations
Holmes, L. B. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.133 · Cited by 181
Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy.
Ornoy, A., & Cohen, E. (1996) · Archives of Disease in Childhood · doi:10.1136/adc.75.6.517 · Cited by 179
Use of topiramate in pregnancy and risk of oral clefts
Margulis, A. V., Mitchell, A. A., Gilboa, S. M., Werler, M. M., Mittleman, M. A., Glynn, R. J., & Hernandez-Diaz, S. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.07.008 · Cited by 179
Vajda, F. J., O'Brien, T. J., Hitchcock, A., Graham, J., Cook, M., Lander, C., & Eadie, M. J. (2004) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2004.05.003 · Cited by 177
Epilepsy, pregnancy and the child
Hughes, J. R. (1982) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(82)90053-0 · Cited by 165
Levetiracetam in pregnancy: Results from the UK and Ireland epilepsy and pregnancy registers
Mawhinney, E., Craig, J., Morrow, J., Russell, A., Smithson, W. H., Parsons, L., Morrison, P. J., Liggan, B., Irwin, B., Delanty, N., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31827f0874 · Cited by 165
Lindhout, D., Meinardi, H., Meijer, J. W. A., & Nau, H. (1992) · PubMed · Cited by 160
Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry
Montouris, G. (2003) · Epilepsy & Behavior · doi:10.1016/s1525-5050(03)00110-0 · Cited by 152
Epilepsy and pregnancy: an obstetric perspective
Richmond, J. R., Krishnamoorthy, P., Andermann, E., & Benjamin, A. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2003.09.020 · Cited by 150
Anticonvulsants, folate levels, and pregnancy outcome: A prospective study
Dansky, L. V., Andermann, E., Rosenblatt, D. S., Sherwin, A. L., & Andermann, F. (1987) · Annals of Neurology · doi:10.1002/ana.410210210 · Cited by 138
Studying the epigenome using next generation sequencing
Ku, C., Naidoo, N., Wu, M., & Soong, R. (2011) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2011-100242 · Cited by 132
Minor anomalies in offspring of epileptic mothers
Gaily, E. K., Granström, M., Hiilesmaa, V. K., & Bardy, A. H. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80162-8 · Cited by 129
Epilepsy and pregnancy: lamotrigine as main drug used
Sabers, A., Dam, M., Rogvi-Hansen, B. Á., Boas, J., Sidenius, P., Friis, M. L., Alving, J., Dahl, M., Ankerhus, J., & Dam, A. M. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.00200.x · Cited by 127
Pregnancy with epilepsy: Obstetric and neonatal outcome of a controlled study
Mawer, G. E., Briggs, M., Baker, G. A., Bromley, R., Coyle, H., Eatock, J., Kerr, L., Kini, U., Kuzmyshcheva, L., Lucas, S. B., et al. (2009) · Seizure · doi:10.1016/j.seizure.2009.11.008 · Cited by 124
Self-citationObstetric outcome in women with epilepsy
Hiilesmaa, V. K., Bardy, A. H., & Teramo, K. A. (1985) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(85)90615-5 · Cited by 123
The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months
Vajda, F. J. E., O'Brien, T. J., Hitchcock, A. A., Graham, J. E., & Lander, C. M. (2003) · Journal of Clinical Neuroscience · doi:10.1016/s0967-5868(03)00158-9 · Cited by 121
Preliminary Results on Pregnancy Outcomes in Women Using Lamotrigine
Tennis, P. S., & Eldridge, R. R. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.45901.x · Cited by 115
Major and minor birth malformations and antiepileptic drugs.
Koch, S., Lösche, G., Jäger‐Roman, E., Jakob, S., Rating, D., Deichl, A., & Helge, H. (1992) · PubMed · Cited by 114
Antiepileptic drug use in women of childbearing age
Meador, K. J., Penovich, P. E., Baker, G. A., Pennell, P. B., Bromfield, E. B., Pack, A. M., Liporace, J. D., Sam, M. C., Kalayjian, L. A., Thurman, D. J., et al. (2009) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2009.04.026 · Cited by 111
Maternal valproate dosage and foetal malformations
Vajda, F. J. E., & Eadie, M. J. (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00458.x · Cited by 110
The Australian Register of Antiepileptic Drugs in Pregnancy: The first 1002 pregnancies
Vajda, F. J. E., Hitchcock, A. A., Graham, J. E., O'Brien, T. J., Lander, C. M., & Eadie, M. J. (2007) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2007.00781.x · Cited by 110
Dravet, C., Julian‐Reynier, C., Legras, C., Magaudda, A., Guerrini, R., Genton, P., Soulayrol, S., Giraud, N., Mesdjian, E., & Trentin, G. A. (1992) · PubMed · Cited by 105
Levetiracetam in pregnancy: Preliminary experience from the UK Epilepsy and Pregnancy Register
Hunt, S., Craig, J. J., Russell, A., Guthrie, E., Parsons, L., Robertson, I., Waddell, R., Irwin, B., Morrison, P. J., & Morrow, J. I. (2006) · Neurology · doi:10.1212/01.wnl.0000244491.48937.55 · Cited by 105
Antiepileptic drugs and intrauterine death: A prospective observational study from EURAP
Tomson, T., Battino, D., Bonizzoni, E., Craig, J. J., Lindhout, D., Perucca, E., Sabers, A., Thomas, S. V., Vajda, F. J. E., & For the EURAP Study Group (2015) · Neurology · doi:10.1212/wnl.0000000000001840 · Cited by 104
Pregnancy outcomes following gabapentin use
Fujii, H., Goel, A., Bernard, N., Pistelli, A., Yates, L. M., Stephens, S., Han, J. Y., Matsui, D. M., Etwell, F., Einarson, T. R., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31828f18c1 · Cited by 101
Diav‐Citrin, O., Shechtman, S., Arnon, J., & Ornoy, A. (2001) · Neurology · doi:10.1212/wnl.57.2.321 · Cited by 101
Cardiac Malformations Are Increased in Infants of Mothers with Epilepsy
Thomas, S. V., Ajaykumar, B., Sindhu, K., Francis, E., Namboodiri, N., Sivasankaran, S., Tharakan, J. A., & Sarma, P. S. (2008) · Pediatric Cardiology · doi:10.1007/s00246-007-9161-4 · Cited by 93
Pregnancy Outcome after In Utero Exposure to Valproate
Diav‐Citrin, O., Shechtman, S., Bar‐Oz, B., Cantrell, D., Arnon, J., & Ornoy, A. (2008) · CNS Drugs · doi:10.2165/00023210-200822040-00004 · Cited by 91
Oxcarbazepine in pregnancy: clinical experience in Argentina
Meischenguiser, R., D’Giano, C., & Ferraro, S. M. (2004) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2003.11.020 · Cited by 89
Teratogenesis in repeated pregnancies in antiepileptic drug‐treated women
Vajda, F. J. E., O'Brien, T. J., Lander, C. M., Graham, J. E., Roten, A., & Eadie, M. J. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03625.x · Cited by 88
Association Between Topiramate and Zonisamide Use During Pregnancy and Low Birth Weight
Hernández–Díaz, S., Mittendorf, R. L., Smith, C. R., Hauser, W. A., Yerby, M. S., & Holmes, L. B. (2013) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000000018 · Cited by 86
Teratogenicity of anticonvulsant drugs. II: A prospective study
Kelly, T. E., Edwards, P., Rein, M., Miller, J. Q., & Dreifuss, F. E. (1984) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320190303 · Cited by 85
Healthcare databases in Europe for studying medicine use and safety during pregnancy
Charlton, R. A., Neville, A. J., Jordan, S. E., Pierini, A., Damase‐Michel, C., Klungsøyr, K., Andersen, A. N., Hansen, A. V., Gini, R., Bos, J., et al. (2014) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3613 · Cited by 85
Epilepsy, pregnancy, and major birth anomalies: an Italian prospective, controlled study.
Tanganelli, P., & Regesta, G. (1992) · PubMed · Cited by 85
Topiramate use in pregnancy and the birth prevalence of oral clefts
Mines, D. I., Tennis, P. S., Curkendall, S. M., Li, D., Peterson, C. A., Andrews, E. B., Calingaert, B., Chen, H., Deshpande, G., Esposito, D. B., et al. (2014) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3612 · Cited by 84
Teratogenicity of the newer antiepileptic drugs – the Australian experience
Vajda, F. J. E., Graham, J. E., Roten, A., Lander, C. M., O'Brien, T. J., & Eadie, M. J. (2011) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2011.08.003 · Cited by 83
Dose dependence of fetal malformations associated with valproate
Vajda, F. J. E., O'Brien, T. J., Graham, J. E., Lander, C. M., & Eadie, M. J. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a43e81 · Cited by 83
Wide, K., Winbladh, B., Tomson, T., Sars‐Zimmer, K., & Berggren, E. (2000) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162200000177 · Cited by 82
Hiilesmaa, V., Teramo, K., Granström, M.-L., & Bardy, A. H. (1983) · BMJ · doi:10.1136/bmj.287.6392.577 · Cited by 79
Intelligence and physical features of children of women with epilepsy
Holmes, L. B., Rosenberger, P. B., Harvey, E. A., Khoshbin, S., & RYAN, L. M. (2000) · Teratology · doi:10.1002/(sici)1096-9926(200003)61:3<196::aid-tera7>3.0.co;2-t · Cited by 78
Malformation in infants of mothers with epilepsy receiving antiepileptic drugs.
Kaneko, S., Otani, K., Kondo, T., Fukushima, Y., Nakamura, Y., Ogawa, Y., Kan, R., Takeda, A., Nakane, Y., & Teranishi, T. (1992) · PubMed · Cited by 78
North American Antiepileptic Drug Pregnancy Registry
Holmes, L. B., & Wyszynski, D. F. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.451102.x · Cited by 77
Pregnancy, Teratogenesis, and Epilepsy
Yerby, M. S. (1994) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30075-6 · Cited by 75
Steegers‐Theunissen, R. P. M., Renier, W. O., Borm, G. F., Thomas, C. M. G., Merkus, H. M. W. M., de Coul, D. A. W. O., de Jong, P. A., van Geijn, H. P., Wouters, M. G. A. J., & Eskes, T. K. A. B. (1994) · Epilepsy Research · doi:10.1016/0920-1211(94)90046-9 · Cited by 75
Malformations in offspring of 305 epileptic women: a prospective study
Battino, D., Binelli, S., Caccamo, M. L., Canevini, M. P., Canger, R., Como, M. L., Croci, D., Giambattista, M. D., Granata, T., Pardi, G., et al. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1992.tb04029.x · Cited by 74
Antiepileptic Drugs during Pregnancy in Primary Care: A UK Population Based Study
Man, S.-L., Petersen, I., Thompson, M., & Nazareth, I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052339 · Cited by 74
The outcome of pregnancy following topiramate treatment: A study on 52 pregnancies
Ornoy, A., Zvi, N., Arnon, J., Wajnberg, R. S., Shechtman, S., & Diav‐Citrin, O. (2008) · Reproductive Toxicology · doi:10.1016/j.reprotox.2008.03.001 · Cited by 73
Kuhnz, W., Koch, S., Jakob, S., Hartmann, A., Helge, H., & Nau, H. (1984) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1984.tb02528.x · Cited by 69
Alsaad, A. M. S., Chaudhry, S. A., & Koren, G. (2015) · Reproductive Toxicology · doi:10.1016/j.reprotox.2015.03.003 · Cited by 66
Outcomes of Pregnancy Associated With Antiepileptic Drugs
Waters, C., Belai, Y., Gott, P. S., Shen, P., & Giorgio, C. M. D. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540150044014 · Cited by 65
Wide, K., Winbladh, B., & n, B. K. X. E. L. X. E. (2004) · Acta Paediatrica · doi:10.1080/08035250310021118 · Cited by 64
Recurrence risk of congenital malformations in infants exposed to antiepileptic drugs in utero
Campbell, E., Devenney, E. M., Morrow, J. I., Russell, A., Smithson, W. H., Parsons, L., Robertson, I., Irwin, B., Morrison, P. J., Hunt, S., et al. (2012) · Epilepsia · doi:10.1111/epi.12001 · Cited by 63
Data Resources for Investigating Drug Exposure during Pregnancy and Associated Outcomes
Charlton, R. A., Cunnington, M. C., de Vries, C. S., & Weil, J. (2008) · Drug Safety · doi:10.2165/00002018-200831010-00004 · Cited by 63
Changing trends in antiepileptic drug prescribing in girls of child-bearing potential
Ackers, R., Besag, F., Wade, A. M., Murray, M. L., & Wong, I. C. K. (2009) · Archives of Disease in Childhood · doi:10.1136/adc.2008.144386 · Cited by 63
Intrauterine growth in the offspring of epileptic women: a prospective multicenter study
Battino, D., Kaneko, S., Andermann, E., AVANZINI, G., Canevini, M. P., Canger, R., Croci, D., Fumarola, C., Guidolin, L., Mamoli, D., et al. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(99)00020-0 · Cited by 60
Gladstone, D. J., Bologa, M., Maguire, C., et al. (1992) · Reproductive Toxicology · doi:10.1016/0890-6238(92)90181-r · Cited by 57
Valproate teratogenicity and epilepsy syndrome
Bromfield, E. B., Dworetzky, B. A., Wyszynski, D. F., Smith, C. R., Baldwin, E. J., & Holmes, L. B. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01696.x · Cited by 57
Antiepileptic drug use by pregnant women enrolled in Florida Medicaid
Wen, X., Meador, K. J., & Hartzema, A. G. (2015) · Neurology · doi:10.1212/wnl.0000000000001304 · Cited by 57
Is lamotrigine a significant human teratogen? Observations from the Australian Pregnancy Register
Vajda, F. J. E., Graham, J. E., Hitchcock, A. A., O'Brien, T. J., Lander, C. M., & Eadie, M. J. (2010) · Seizure · doi:10.1016/j.seizure.2010.07.019 · Cited by 55
Kuhnz, W., Jäger‐Roman, E., Rating, D., Deichl, A., Kunze, J., Helge, H., & Nau, H. (1983) · PubMed · Cited by 54
Oguni, M., Dansky, L. V., Andermann, E., Sherwin, A. L., & Andermann, F. (1992) · Brain and Development · doi:10.1016/s0387-7604(12)80343-3 · Cited by 49
Anticonvulsant teratogenesis: I. A study design for newborn infants
Holmes, L. B., Harvey, E. A., Brown, K. S., Hayes, A. M., & Khoshbin, S. (1994) · Teratology · doi:10.1002/tera.1420490316 · Cited by 49
Teratogenicity of antiepileptic drugs
Starreveld-Zimmerman, A. A. E., van der Kolk, W. J., Elshove, J., & Meinardi, H. (1974) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(74)80001-6 · Cited by 48
Australian Pregnancy Registry of Women Taking Antiepileptic Drugs
Vajda, F. J. E., Lander, C. M., O'Brien, T. J., Hitchcock, A. A., Graham, J. E., Solinas, C., Eadie, M. J., & Cook, M. J. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.451103.x · Cited by 48
Holmes, L. B., Coull, B. A., Dorfman, J. D., & Rosenberger, P. B. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.08.048 · Cited by 48
Prenatal diagnosis of spina bifida aperta after first‐trimester valproate exposure
Omtzigt, J. G. C., Los, F. J., Hagenaars, A. M., Stewart, P. A., Sachs, E. S., & Lindhout, D. (1992) · Prenatal Diagnosis · doi:10.1002/pd.1970121107 · Cited by 46
Fetal phenytoin exposure, hypoplastic nails, and jitteriness.
D'Souza, S. W., Robertson, I. G., Donnai, D., & Mawer, G. E. (1991) · Archives of Disease in Childhood · doi:10.1136/adc.66.3.320 · Cited by 45
Developmental Enamel Defects in Children Prenatally Exposed to Anti-Epileptic Drugs
Jacobsen, P. E., Henriksen, T. B., Haubek, D., & Østergaard, J. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058213 · Cited by 44
Meadow, R. (1991) · Archives of Disease in Childhood · doi:10.1136/adc.66.1_spec_no.62 · Cited by 38
The International Lamotrigine Pregnancy Registry Update for the Epilepsy Foundation
Cunnington, M. C. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.451105.x · Cited by 37
Koch, S., Göpfert-Geyer, I., Jäger‐Roman, E., Jakob, S., Huth, H., Hartmann, A., Rating, D., & Helge, H. (2008) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2008-1069536 · Cited by 35
Nakane, Y. (1979) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1979.tb00771.x · Cited by 32
Developing diagnostic criteria for the fetal anticonvulsant syndromes
Dean, J., Moore, S., & Turnpenny, P. D. (2000) · Seizure · doi:10.1053/seiz.2000.0392 · Cited by 31
Cassina, M., Dilaghi, A., Gianantonio, E. D., Cesari, E., Santis, M. D., Mannaioni, G., Pistelli, A., & Clementi, M. (2013) · Reproductive Toxicology · doi:10.1016/j.reprotox.2013.04.002 · Cited by 31
The fetal safety of Levetiracetam: A systematic review
Chaudhry, S. A., Jong, G., & Koren, G. (2014) · Reproductive Toxicology · doi:10.1016/j.reprotox.2014.02.004 · Cited by 30
Vajda, F. J. E., Lander, C. M., Hitchcock, A. A., et al. (2007) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2006.04.025 · Cited by 29
Clinical, morphological, and biochemical phenotype of a new case of Ehlers-Danlos syndrome type VIIC
Fujimoto, A., Wilcox, W. R., & Cohn, D. H. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19970110)68:1<18::aid-ajmg4>3.0.co;2-u · Cited by 28
Outcome of pregnancies in epileptic women: a study in Saudi Arabia
MRCP, M. A. B., & MRCOG, Z. A.-T. (1999) · Seizure · doi:10.1053/seiz.1998.0239 · Cited by 24
Checking the health of school entrants.
Whitmore, K., & BAX, M. C. O. (1990) · Archives of Disease in Childhood · doi:10.1136/adc.65.3.320 · Cited by 23
Pregnancy and teratogenicity of antiepileptic drugs.
Eroğlu, E., Gökçil, Z., Bek, S., Ulaş, Ü. H., & Odabaşı, Z. (2008) · PubMed · Cited by 17
Bag, S., Behari, M., Gk, A., & Karmarkar, M. G. (1989) · Journal of Neurology · doi:10.1007/bf00314466 · Cited by 17
[Is valproic acid teratogenic?].
Robert, E., Robert, J., & Lapras, C. (1983) · PubMed · Cited by 17
Teratogenicity of Antiepileptic Drugs and Drug Specific Malformations
Kaneko, S., Otani, K., Kondo, T., Fukushima, Y., Kan, R., Takeda, A., & Nakane, Y. (1993) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1993.tb02084.x · Cited by 15
Physical growth and psychomotor development of infants exposed to antiepileptic drugsin utero
Dhanaraj, M., Rangaraj, R., Vengatesan, A., et al. (2006) · Neurology India · doi:10.4103/0028-3886.24701 · Cited by 15
Ferri, M. M., Mayor, P. P., López-Fraile, I. P., Vilanova, M. D. C., Escartín, A., Moro, M. M., & Berdusán, M. I. F. (2009) · PubMed · Cited by 11
Treatment for epilepsy in pregnancy: congenital malformation outcomes in the child
Pulman, J., Bromley, R., Adab, N., Greenhalgh, J., McKay, A. J., Smith, C. T., Dickson, R., & Marson, A. G. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010224 · Cited by 10
Self-citationBegum, S., Sarma, P. S., & Thomas, S. V. (2013) · Epilepsia · doi:10.1111/epi.12411 · Cited by 9
Arteaga‐Vázquez, J., Luna‐Muñoz, L., & Mutchinick, O. M. (2012) · Salud Pública de México · doi:10.1590/s0036-36342012000600006 · Cited by 7
Meadow, R. (1991) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199108000-00006 · Cited by 5
Cited by
Idiopathic intracranial hypertension: consensus guidelines on management
Mollan, S. P., Davies, B., Silver, N. C., Shaw, S., Mallucci, C. L., Wakerley, B. R., Krishnan, A., Chavda, S. V., Ramalingam, S., Edwards, J., et al. (2018) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-317440 · Cited by 612
Asadi-Pooya, A. A., Brigo, F., Lattanzi, S., & Blumcke, I. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01048-6 · Cited by 265
30 years of second-generation antiseizure medications: impact and future perspectives
Perucca, E., Brodie, M. J., Kwan, P., & Tomson, T. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30035-1 · Cited by 261
Tomson, T., Battino, D., Bromley, R., Kochen, S., Meador, K., Pennell, P., & Thomas, S. V. (2019) · Epileptic Disorders · doi:10.1684/epd.2019.1105 · Cited by 256
Self-citationChristensen, J., Pedersen, L., Sun, Y., Dreier, J. W., Brikell, I., & Dalsgaard, S. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.6606 · Cited by 127
Metadata
- Authors
- Weston, J., Bromley, R., Jackson, C. F., Adab, N., Clayton-Smith, J., Greenhalgh, J., Hounsome, J., McKay, A. J., Tudur Smith, C., & Marson, A. G.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2016-11-07
- Volume
- 2017
- Issue
- 4
- Pages
- CD010224-CD010224
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2551860952
- Cited by
- 347
- References
- 127
- FWCI
- 39.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.